 NEW YORK, Dec. 16, 2020 GLOBE NEWSWIRE -- Ovid Therapeutics Inc. NASDAQ: OVID, a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced that it has been added to the Nasdaq Biotechnology Index Nasdaq: NBI. The addition will become effective prior to market open on Monday, December 21, 2020. 